细胞周期蛋白依赖性激酶4/6抑制剂联合氟维斯群治疗HR阳性 / HER2阴性晚期乳腺癌患者的临床综合评价
曹可鸣, 陈威, 尚荣国, 王靖欣, 孙静波, 薛文鑫
Clinical comprehensive evaluation of CDK4/6 inhibitor combined with fulvestrant in HR+/HER2-advanced breast cancer patients
Keming CAO, Wei CHEN, Rongguo SHANG, Jingxin WANG, Jingbo SUN, Wenxin XUE
临床药物治疗杂志
.
2024, (Z1): 74
-80
.
DOI: 10.3969/j.issn.1672-3384.2024.Z1.011
